US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

52.32

-1.2200-2.28%

Post-market: 52.420.1000+0.19%19:20 EDT

Volume:5.49M

Turnover:288.52M

Market Cap:128.08B

PE:22.76

High:52.92

Open:52.86

Low:52.23

Close:53.54

Loading ...

Overview Company News Filings

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS

SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

NRIX Stock Up as SNY In-Licenses Rights to Autoimmune Diseases Program

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program

MT Newswires Live

Nurix Therapeutics in Expanded Collaboration with Sanofi

Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ

Sanofi treatment of immunoglobulin G4-related disease granted orphan status

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

FDA Approves Sanofi's Hemophilia Drug

Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

Sanofi Hemophilia Treatment Receives FDA Approval

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

MT Newswires Live

Innate Pharma SA (IPHA) (FY 2024) Earnings Call Highlights: Strategic Advances and Financial ...

Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD

Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNY/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","market":"US","secType":"STK","nameCN":"Sanofi SA","latestPrice":52.32,"timestamp":1745611200000,"preClose":53.54,"halted":0,"volume":5488691,"hourTrading":{"tag":"盘后","latestPrice":52.42,"preClose":52.32,"latestTime":"19:20 EDT","volume":17285,"amount":904819.14,"timestamp":1745623210076},"delay":0,"floatShares":2205948514,"shares":2448069980,"eps":2.298867,"marketStatus":"Market Closed","change":-1.22,"latestTime":"04-25 16:00:00 EDT","open":52.86,"high":52.92,"low":52.225,"amount":288515951.42123,"amplitude":0.012981,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.298867,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":1,"adrRate":0.5,"listingDate":1025496000000,"exchange":"NASDAQ","adjPreClose":53.54,"dividendRate":0.042633,"preHourTrading":{"tag":"盘前","latestPrice":52.9,"preClose":53.54,"latestTime":"09:28 EDT","volume":286184,"amount":15125377.593672,"timestamp":1745587680217},"postHourTrading":{"tag":"盘后","latestPrice":52.42,"preClose":52.32,"latestTime":"19:20 EDT","volume":17285,"amount":904819.14,"timestamp":1745623210076},"volumeRatio":1.6082988738407291,"impliedVol":0.2786,"impliedVolPercentile":0.516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","floatShares":2205948514,"roa":"4.28%","roe":"7.30%","lyrEps":2.29994,"volumeRatio":1.6082988738407291,"shares":2448069980,"dividePrice":2.234637,"high":52.92,"amplitude":0.012981,"preClose":53.54,"low":52.225,"week52Low":45.8,"pbRate":"1.45","psRate":"2.49","week52High":60.115,"institutionHeld":0.0837,"latestPrice":52.32,"eps":2.298867,"divideRate":0.042633,"volume":5488691,"delay":0,"ttmEps":2.298867,"open":52.86,"prevYearClose":48.23,"prevWeekClose":50.9,"prevMonthClose":55.46,"prevQuarterClose":55.46,"fiveDayClose":50.9,"twentyDayClose":54.91,"sixtyDayClose":52.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNY\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524784382","title":"Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2524784382","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524784382?lang=en_us&edition=fundamental","pubTime":"2025-04-04 21:46","pubTimestamp":1743774360,"startTime":"0","endTime":"0","summary":"This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy and the expanded use of AstraZeneca’s AZN blockbuster cancer drug, Imfinzi. J&J’s JNJ bankruptcy strategy to settle talc lawsuits failed for the third time. The European Commission approved Pfizer’s PFE respiratory syncytial virus vaccine, Abrysvo, for use in adults aged 18 through 59 years.Here's a recap of the week’s most important stories.Texas Court Rejects J&J’s Bankruptcy Attempt to End Talc Suits. A bankruptcy court in Texas rejected J&J’s proposed bankruptcy plan to settle claims related to its talc lawsuits for the third time. In September, J&J, via a subsidiary called Red River Talc, filed for voluntary bankruptcy in the Southern District of Texas after it received the support of around 83% of current claimants for the proposed bankruptcy plan, which was above the 75% required by the U.S. bankruptcy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-fda-nod-134600557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1674673691.USD","SG9999013999.USD","LU0114720955.EUR","IE00B3PB1722.GBP","LU0070302665.USD","SNY","IE00B1BXHZ80.USD","JNJ","LU0225284248.USD","LU0912757837.SGD","LU0058720904.USD","IE00BVYPNW00.USD","IE00BJT1NW94.SGD","LU0345770993.USD","LU2133065610.SGD","LU2592432038.USD","AZN","NVS","BK4599","LU0345770308.USD","LU2430703178.SGD","LU1778281490.HKD","BK4532","CHMP","LU0306807586.USD","LU2129689605.HKD","LU0889566641.SGD","IE00B2B36J28.USD","LU1430594728.SGD","SG9999001440.SGD","LU1894683264.USD","BK4585","LU2112291526.USD","IE00BSNM7G36.USD","LU0289739699.SGD","PFE","LU0868494617.USD","BK4533","LU1244550221.USD","LU1732799900.SGD","LU2602419157.SGD","SG9999001176.USD","LU1267930813.SGD","LU2129689431.USD","LU0320765992.SGD","LU0985320562.USD","LU1585245621.USD","IE00BLSP4239.USD","LU1280957306.USD","LU1261432733.SGD"],"gpt_icon":1},{"id":"2524290290","title":"FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS","url":"https://stock-news.laohu8.com/highlight/detail?id=2524290290","media":"Yahoo Finance","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524290290?lang=en_us&edition=fundamental","pubTime":"2025-04-04 03:39","pubTimestamp":1743709147,"startTime":"0","endTime":"0","summary":"The US Food and Drug Administration was supposed to make a final decision about whether or not to approve Novavax's  COVID-19 vaccine this week, but that deadline has passed with no clarity on when the decision will move forward again.The vaccine remains available under the emergency use authorization  it received during the pandemic.But the delayed decision and missed deadline, first reported by the Wall Street Journal, could signal further pain ahead for the pharmaceutical and biotech sectors, especially vaccine companies: a fear that has been mounting in the wake of mass layoffs at the health agencies this week.Education Secretary nominee Linda McMahon , and U.S. Health and Human Services Secretary Robert F. . Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-delay-on-novavax-vaccine-approval-could-be-bellwether-for-vaccine-sector-bofas-193907654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","LU1032955483.USD","SNY","LU1023059063.AUD","LU0289739699.SGD","LU1057294990.SGD","LU1674673691.USD","L","IE00B2B36J28.USD","LU0053666078.USD","LU0795875169.SGD","BK4547","LU1032466523.USD","JNJ","LU1929549753.HKD","LU0058720904.USD","LU1778281490.HKD","NVAX","LU1244550221.USD","LU2129689514.USD","LU1066051811.HKD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1066051225.USD","LU1280957306.USD","LU1261432733.SGD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU0345769631.USD","LU2602419157.SGD","LU2430703095.HKD","IE00BVYPNV92.GBP","MRNA","LU0203347892.USD","BK4532","IE00B19Z3B42.SGD","IE00BDGV0183.EUR","LU0345770308.USD","BK4548","LU1674673428.USD","IE00BJJMRZ35.SGD","LU0345770993.USD","LU2129689431.USD","BK4592","LU0098860793.USD","BK4501","LU1267930813.SGD","LU1506573853.SGD","LU2505996509.AUD"],"gpt_icon":1},{"id":"2524296191","title":"SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2524296191","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524296191?lang=en_us&edition=fundamental","pubTime":"2025-04-03 23:27","pubTimestamp":1743694020,"startTime":"0","endTime":"0","summary":"Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, for the treatment of warm autoimmune hemolytic anemia  and IgG4-related disease .The candidate is being developed in separate mid-stage studies for treating wAIHA and IgG4-RD, two rare diseases.Currently, there are no approved therapies for treating wAIHA and IgG4-RD. Both diseases have a significant unmet medical need.The FDA grants orphan drug designation to support the development of medicines for rare disorders that affect less than 200,000 patients in the United States.Sanofi has developed rilzabrutinib for treating immune thrombocytopenia , another rare, complex autoimmune disorder.A regulatory application seeking approval for rilzabrutinib for treating ITP is currently under review in the United States. A final decision from the FDA is expected on Aug. 29, 2025. The regulatory body has previously granted a fast-track designation and an orphan drug designatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/snys-rilzabrutinib-gets-fdas-orphan-152700727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4533","LU0823416689.USD","BK4532","KRYS","LU0889565916.HKD","LU0109394709.USD","IE00BFXG1179.USD","BK4588","DVAX","IE00BN0W2T93.GBP","JAZZ","BK4007","SNY","BK4585","BK4139","LU0320765992.SGD"],"gpt_icon":0},{"id":"1121702600","title":"Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1121702600","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121702600?lang=en_us&edition=fundamental","pubTime":"2025-04-03 22:00","pubTimestamp":1743688825,"startTime":"0","endTime":"0","summary":"LONDON/BENGALURU April 3 (Reuters) - Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from reciprocal tariffs, but executives and ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO","LLY","OCGN","SNY","GSK","GILD","MRK","MRNA","VXRT","PFE","AZN","VERU","BNTX","REGN","VIR","ABT","NVAX","JNJ"],"gpt_icon":1},{"id":"2524419264","title":"NRIX Stock Up as SNY In-Licenses Rights to Autoimmune Diseases Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2524419264","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524419264?lang=en_us&edition=fundamental","pubTime":"2025-04-03 21:08","pubTimestamp":1743685680,"startTime":"0","endTime":"0","summary":"Nurix TherapeuticsNRIX shares rose 8.7% on Wednesday after the company announced that Sanofi SNY has in-licensed exclusive rights to an undisclosed Nurix program aimed at a previously untreatable transcription factor for autoimmune diseases. This undisclosed target plays a key role in regulating inflammation and is separate from the previously revealed STAT6 degrader program, signed between the companies in 2019. The stock is gaining further in the pre-market hours on Thursday.Nurix and Sanofi first established a strategic collaboration in 2019 to develop and commercialize a portfolio of targeted protein degradation therapies for patients with complex diseases across various therapeutic areas. The partnership utilizes NRIX’s proprietary DEL-AI discovery platform to discover small molecules that promote the degradation of three initially designated drug targets. In 2021, Sanofi exercised its option to expand the number of targets from three to five.The latest update further expands the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrix-stock-sny-licenses-rights-130800564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFXG1179.USD","BK4585","BK4532","NRIX","BK4007","LU0566484027.USD","BK4139","LU1559883803.SGD","SNY","BAYRY","BK4588"],"gpt_icon":1},{"id":"2524832162","title":"Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2524832162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524832162?lang=en_us&edition=fundamental","pubTime":"2025-04-03 15:51","pubTimestamp":1743666660,"startTime":"0","endTime":"0","summary":"0751 GMT - Big Pharma stocks are up after U.S. President Trump exempted pharmaceuticals for now from his reciprocal tariffs on global imports. \"It is still somewhat unclear whether the broader reaching 10% baseline tariffs could still be levied against imported drugs and vaccines, in our view,\" Shore Capital analyst Sean Conroy says in a note. Likewise, Bryan Garnier Research analysts say in a note that the pharma industry is left uncertain about an actual tariff risk given Trump's mixed remarks that drugmakers \"will come roaring back to the U.S., because if they don't, they got a big tax to pay.\" Novartis and Sanofi are up 0.6% and 0.3%, respectively. The U.K's AstraZeneca and GSK rose 1% and 1.6%, respectively. Swiss pharma giant Roche is down 2.3% after its multiple-sclerosis drug Ocrevus failed to meet its primary endpoint. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4532","IE00BJT1NW94.SGD","LU2417539215.USD","LU2462157665.USD","IE00B2B36J28.USD","BK4588","RHHBY","BK4007","NVS","03165","SNY","LU1829250122.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","GSK.UK","LU0320765992.SGD","IE0002141913.USD","LU0320765489.SGD","BK4568","LU0070302665.USD","BK4585","LU0889565916.HKD","LU0208291251.USD","IE00BFXG1179.USD","IE0009355771.USD","LU2236285917.USD","LU0211331839.USD","AZN","GSK","LU2456880835.USD","BK4578"],"gpt_icon":1},{"id":"2524595405","title":"Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2524595405","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524595405?lang=en_us&edition=fundamental","pubTime":"2025-04-03 13:00","pubTimestamp":1743656400,"startTime":"0","endTime":"0","summary":"Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease. Rilzabrutinib is currently under regulatory review in the US, EU and China for potential use in immune thrombocytopenia. Paris, April 3, 2025. The US Food and Drug Administration  has granted orphan drug designation to rilzabrutinib, an investigational, novel, advanced, oral, reversible Bruton’s tyrosine kinase  inhibitor, for two rare diseases, warm autoimmune hemolytic anemia  and IgG4-related disease . There is still a significant unmet medical need for these two rare diseases, and neither have any currently approved medicine. FDA grants orphan drug designation to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people in the US.About rilzabrutinib Rilzabrutinib is an investigational, oral, reversible, BTK inhibitor that has the potential to be a first- and best-in-class treatment of several immune-mediated diseases. BTK, expressed in B cells, mac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-rilzabrutinib-granted-orphan-050000915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","ITP","IE00BFXG1179.USD","BK4199","SNY","BK4585","BK4007"],"gpt_icon":0},{"id":"2524464194","title":"Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2524464194","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524464194?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:46","pubTimestamp":1743594368,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics  said Wednesday that Sanofi  has exclusively licensed an undisclosed Nurix program targeting a previously undruggable transcription factor for autoimmune diseases.The company said the target is a key regulator of inflammation and is separate from its earlier disclosed STAT6 degrader program.Under the collaboration, Nurix said it will use its DEL-AI drug discovery platform to identify new agents that utilize E3 ligases to degrade the target.Sanofi has the right to license drug candidates resulting from the work, while Nurix has the option to co-develop and co-promote up to two products in the US after clinical proof of concept, it added.For programs where Nurix doesn't exercise its co-development option, it will receive milestones and royalties based on global sales, the company said.Nurix said it received a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the total amount to date to $105 million, and is eligible for up to","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4139","SNYNF","SNY","NRIX","BK4007","IE00BFXG1179.USD","BK4588"],"gpt_icon":0},{"id":"2524461423","title":"Nurix Therapeutics in Expanded Collaboration with Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2524461423","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524461423?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:33","pubTimestamp":1743593580,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics has widened its collaboration with Sanofi, granting the French pharmaceutical company an exclusive license to an undisclosed program targeting a previously undruggable transcription factor for autoimmune diseases.Nurix on Wednesday said it received a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the total amount the San Francisco clinical-stage biopharmaceutical company has received to date under the pact to $105 million.Nurix said the new collaboration target is a central regulator of the inflammation response and is distinct from the companies' existing STAT6 degrader program.Nurix said it remains eligible for up to $465 million in development, regulatory and commercial milestone payments per licensed program under its work with Sanofi, as well as royalties on future sales.Shares of Nurix were recently up 3.1% to $10.79 in premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","SNYNF","BK4007","BK4139","SNY","IE00BFXG1179.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2524451039","title":"Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2524451039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524451039?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:27","pubTimestamp":1743586020,"startTime":"0","endTime":"0","summary":"Tesla : The e-vehicle maker's quarterly delivery figures are expected early Wednesday. Shares shed about 1% ahead of the open. The stock has slid this year amid a consumer backlash to Elon Musk's political activities, and tariff uncertainty.Auto stocks: In Germany, shares of automotive supplier Continental  and BMW  both declined. In Asia, Hyundai  lost 1.2%. Ford , General Motors  and Jeep maker Stellantis  were little changed in U.S. premarket trading.Global pharma stocks: Danish Ozempic maker Novo Nordisk  fell more than 2%. Also under pressure: Germany's Bayer , France's Sanofi  and the U.K.'s GSK . Most U.S. drug makers were little changed ahead of the bell.Newsmax : Shares slid more than 30% premarket, continuing a rollercoaster first week of trading for the conservative TV outlet.Grifols : Private-equity firm Brookfield Asset Management  has reopened takeover talks with Grifols. The pharmaceutical company's shares jumped 14% in Madrid midday trading.This item is part of a Wall S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","SNY","BK4574","TSLL","NVO","LU0648000940.SGD","LU2750360641.GBP","GRFS","LU0234570918.USD","LU2357305700.SGD","LU2756315664.SGD","BAYRY","BK4598","LU1201861165.SGD","GSK.UK","BK4527","SG9999015945.SGD","F","SG9999015978.USD","BK4612","CTTAY","LU0648001328.SGD","BK4550","LU0820561909.HKD","LU1861220033.SGD","BK4561","GM","LU0211331839.USD","LU1551013342.USD","BK4532","NMAX","BK4566","LU1064927863.SGD","LU1914381329.SGD","LU1066051225.USD","LU1066053197.SGD","BK4007","LU0345770308.USD","LU1839511570.USD","LU2108987350.USD","TSYW.SI","LU0820562030.AUD","BK4533","LU1548497426.USD","TSLA","STLA","LU1093756325.SGD","LU0345769631.USD","GSK","LU1720051108.HKD"],"gpt_icon":1},{"id":"2524142638","title":"Sanofi treatment of immunoglobulin G4-related disease granted orphan status","url":"https://stock-news.laohu8.com/highlight/detail?id=2524142638","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524142638?lang=en_us&edition=fundamental","pubTime":"2025-04-02 00:35","pubTimestamp":1743525312,"startTime":"0","endTime":"0","summary":"The FDA granted Sanofi (SNY) US Services’ rilzabrutinib orphan designation as a treatment of immunoglobulin G4-related disease, according to a post...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sanofi-treatment-of-immunoglobulin-g4-related-disease-granted-orphan-status?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sanofi-treatment-of-immunoglobulin-g4-related-disease-granted-orphan-status?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","IE00BFXG1179.USD","SNYNF","SNY"],"gpt_icon":0},{"id":"2524145956","title":"SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2524145956","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524145956?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:44","pubTimestamp":1743515040,"startTime":"0","endTime":"0","summary":"SanofiSNY and partner,Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia  as the first antithrombin-lowering  therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients  with hemophilia A or B with or without factor VIII or IX inhibitors in the United States.Hemophilia A and B are rare, lifelong congenital bleeding disorders that impair the blood's ability to clot, causing excessive bleeding and spontaneous joint bleeds. These can lead to joint damage, chronic pain, which takes a significant toll on the patients’ quality of life.This FDA approval is based on positive data from the phase III ATLAS studies of Qfitlia, which showed clinically significant bleed protection, as measured by annualized bleeding rates , in hemophilia patients with or without inhibitors.Year to date, SNY stock has gained 15% compared with the industry’s 3.4% growth.Further analysis in the open-label extension study, under the ATL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sny-gets-fda-nod-first-134400996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","IE00BFXG1179.USD","LU1559883803.SGD","ABR","CORT","BK4211","UBCP","BK4110","SNY","LU0566484027.USD","BK4532","ALNY","BK4588","BAYRY","BK4585","BK4139","BK4548"],"gpt_icon":0},{"id":"1185252208","title":"Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1185252208","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185252208?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:38","pubTimestamp":1743428305,"startTime":"0","endTime":"0","summary":"Moderna Shares Down 14% Premarket After Report Top Vaccine Official Peter Marks Forced Out at FDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Moderna Shares Tumble After Report Top Vaccine Official Peter Marks Forced Out at FDA","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","MRK","NVAX","OCGN","SNY","VERU","IBIO","VIR","GSK","REGN","MRNA","BNTX","JNJ","GILD","LLY","AZN","VXRT","ABT"],"gpt_icon":1},{"id":"2523949132","title":"FDA Approves Sanofi's Hemophilia Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2523949132","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523949132?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:28","pubTimestamp":1743424092,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration on Friday approved Sanofi SA’s  Qfitlia , the first antithrombin-lowering  therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients  with hemophilia A or B with or without factor VIII or IX inhibitors.The approval is based on data from the ATLAS phase 3 studies that demonstrated clinically meaningful bleed protection as measured by annualized bleeding rates .Also Read: Sanofi Strengthens Its Immune System-Focused Pipeline With Around $2 Billion Dren Bio Deal. By lowering AT, a protein that inhibits blood clotting, Qfitlia helps increase thrombin generation to restore hemostasis in hemophilia patients.In the ATLAS clinical development program, Qfitlia demonstrated low bleed rates across subgroups with as few as six injections a year. Key results include:. Significant bleed reduction by 71% in ABR for patients without inhibitors treated with Qfitlia prophylaxis compared to clotting factor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-sanofis-hemophilia-drug-122812095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABR","BK4548","SNY","SNYNF","ALNY","BK4139","BK4585","BK4007","BK4110","BK4588","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2523639953","title":"Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2523639953","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523639953?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:07","pubTimestamp":1743192420,"startTime":"0","endTime":"0","summary":"Qfitlia , the first antithrombin-lowering therapy in hemophilia, offers consistent protection with as few as six injections a year via a prefilled pen or vial and syringe. Unique mechanism helps reduce the frequency of bleeding episodes for people with hemophilia. Paris, March 28, 2025. The US Food and Drug Administration  has approved Qfitlia , the first antithrombin-lowering  therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients  with hemophilia A or B with or without factor VIII or IX inhibitors. The approval is based on data from the ATLAS phase 3 studies that demonstrated clinically meaningful bleed protection as measured by annualized bleeding rates  across hemophilia patients with or without inhibitors.Significant bleed reduction by 71% in ABR for patients without inhibitors treated with Qfitlia prophylaxis compared to clotting factor concen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-qfitlia-approved-first-200700830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNY","BK4007","IE00BFXG1179.USD","BK4585","ABR","BK4588","BK4110"],"gpt_icon":0},{"id":"2523416687","title":"Sanofi Hemophilia Treatment Receives FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2523416687","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523416687?lang=en_us&edition=fundamental","pubTime":"2025-03-29 03:54","pubTimestamp":1743191643,"startTime":"0","endTime":"0","summary":"Sanofi  received the US Food and Drug Administration approval for Qfitlia used to prevent bleeding in patients aged at least 12 with hemophilia A or B, according to a statement by the FDA Friday.Qfitlia reduces antithrombin levels to improve blood clotting instead of replacing missing clotting factors, according to the statement.The medicine is administered subcutaneously, initially once every two months, and the dosage is adjusted using the FDA-approved Innovance Antithrombin test, the FDA said in its statement. The fixed dose of Qfitlia is not FDA approved because it led to excessive clotting in some patients.Qfitlia's safety and effectiveness were confirmed in two studies involving 177 male patients, comparing its use to traditional on-demand treatments, the statement added. Qfitlia reduced bleeding rates by 73% in patients with inhibitors and 71% in those without inhibitors compared to standard treatments.Qfitlia carries serious warnings about blood clot risks, gallbladder disease,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","BK4588","SNYNF","BK4007","SNY","BK4585"],"gpt_icon":0},{"id":"2522250119","title":"European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2522250119","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522250119?lang=en_us&edition=fundamental","pubTime":"2025-03-28 23:09","pubTimestamp":1743174595,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.49% to 1,404.43 on the S&P Europe Select ADR Index, which is about 1.5% lower for the week.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Genfit , which advanced 49% and 5.2% respectively. They were followed by pharmaceutical company Sanofi , which rose 1.5%.The decliners from continental Europe were led by internet advertising firm Criteo , which fell 3.6%. It was followed by internet browser company Opera  and financial services company Banco Bilbao Vizcaya Argentaria , which were down 3.1% and 2.8% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana  and utilities provider National Grid , which increased 5.6% and 2.9% respectively. They were followed by telecommunications operator Vodafone Group  and biopharmaceutical company Adaptimmune Therapeutics , which were up 2% and 1.6% re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","ADAP","SNY","AFG","BK4023","DBVT","BK4009","BK4521","BK4207","BBVA","BCS","BK4139","AMRN","MREO","BK4505","IE00BFMHRM44.USD","GNFT","NCNA","BK4107","IE00BFXG1179.USD","NGG","BK4208","CUK","BK4585","BK4532","BK4007","CRTO","BK4132","BK4142","VOD","OPRA","BK4588"],"gpt_icon":0},{"id":"2522519428","title":"Innate Pharma SA (IPHA) (FY 2024) Earnings Call Highlights: Strategic Advances and Financial ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2522519428","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522519428?lang=en_us&edition=fundamental","pubTime":"2025-03-28 15:01","pubTimestamp":1743145305,"startTime":"0","endTime":"0","summary":"Revenue and Other Income: 20.1 million in 2024, primarily from collaboration licensing agreements  and a research tax credit .Operating Expenses: 71.7 million in 2024, with 73% related to R&D.General and Administrative Expenses: 19.7 million in 2024, an increase of 1.4 million from the previous year.R&D Expenses: 52 million in 2024, a reduction of 4 million from the prior year.Cash and Financial Assets: 91.1 million as of December 31, 2024.Financial Liabilities: 31 million, down from 39.9 million at the end of 2023.GuruFocus has detected 6 Warning Signs with IPHA.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Innate Pharma SA  successfully recruited the first patients into the phase 1 dose-finding trial for IPH 65, marking a critical step in its clinical development.Q: What are Innate Pharma's expectations for IPH 6,501 in the non-Hodgkin lymphoma  market, considering the underperformance of recent CD-19 targeted therapies?Q: Is Sano","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innate-pharma-sa-ipha-fy-070145850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IPHA","SNY"],"gpt_icon":0},{"id":"2522518458","title":"Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD","url":"https://stock-news.laohu8.com/highlight/detail?id=2522518458","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522518458?lang=en_us&edition=fundamental","pubTime":"2025-03-28 14:00","pubTimestamp":1743141600,"startTime":"0","endTime":"0","summary":"Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adults with elevated eosinophils. Approval marks the first new treatment approach for COPD in more than a decade in Japan and the sixth approved indication for chronic diseases with underlying type 2 inflammation. Paris and Tarrytown, NY, March 28, 2025. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent  for the treatment of chronic obstructive pulmonary disease  in adults whose disease is not adequately controlled with existing therapy.About Sanofi and Regeneron’s COPD clinical research programSanofi and Regeneron are motivated to transform the treatment paradigm of COPD by examining the role different types of inflammation","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-dupixent-approved-first-060000979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","LU2237438978.USD","BK4139","BK4585","REGN","LU2023250504.SGD","LU0882574055.USD","BK4588","LU2468319806.SGD","LU0114720955.EUR","LU2362541273.HKD","LU2089984988.USD","LU1917777945.USD","LU2362540622.SGD","LU0109394709.USD","LU0058720904.USD","LU2106854487.HKD","BK4007","SNY","LU1974910355.USD","LU0823416689.USD","LU2362541513.USD","LU0289739699.SGD","LU0053666078.USD","IE00BFXG1179.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2522051811","title":"Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522051811","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522051811?lang=en_us&edition=fundamental","pubTime":"2025-03-28 14:00","pubTimestamp":1743141600,"startTime":"0","endTime":"0","summary":"Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for COP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/28/3051139/0/en/Dupixent-dupilumab-Approved-as-the-First-ever-Biologic-Medicine-in-Japan-for-Patients-with-Chronic-Obstructive-Pulmonary-Disease-COPD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","SNY","LU0114720955.EUR","BK4139","BK4007","LU1917777945.USD","LU0289739699.SGD","IE00BFXG1179.USD","LU0823416689.USD","BK4156","PN","LU1974910355.USD","LU0058720904.USD","BK4096","BK4588","LU2237438978.USD","BK4585","LU2362541513.USD","REGN","LU2023250504.SGD","LU0889565916.HKD","LU0882574055.USD","LU2362540622.SGD","LU0109394709.USD","LU2468319806.SGD","LU2362541273.HKD","LU0320765992.SGD","LU2106854487.HKD","LU2089984988.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNY\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"SNY","amount":2.212154,"announcedDate":"2025-04-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"赛诺菲安万特","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-06-12"},{"market":"US","date":"2025-04-24","symbol":"SNY","fiscalQuarterEnding":"2025/03","expectedEps":0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745467200000,"reportTimeType":"pre","actualEps":0.94},{"market":"US","date":"2025-01-30","symbol":"SNY","fiscalQuarterEnding":"2024/12","expectedEps":0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.7},{"market":"US","date":"2024-10-25","symbol":"SNY","fiscalQuarterEnding":"2024/09","expectedEps":1.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1729828800000,"reportTimeType":"pre","actualEps":1.57},{"date":"2024-09-12","symbol":"SNY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1726128000000,"name":null,"time":"Pre-Market","dateTimestamp":1726113600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNY\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-06","recordDate":"2015-05-08","paymentDate":"2015-06-02","value":1.086507,"currency":"USD"},{"executeDate":"2016-05-05","recordDate":"2016-05-09","paymentDate":"2016-06-01","value":1.124297,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":"2017-05-15","paymentDate":"2017-06-07","value":1.053962,"currency":"USD"},{"executeDate":"2018-05-09","recordDate":"2018-05-10","paymentDate":"2018-06-04","value":1.252612,"currency":"USD"},{"executeDate":"2019-05-07","recordDate":"2019-05-08","paymentDate":"2019-05-31","value":1.739462,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.2857,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1742616000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNY","date":"2025-04-24","current":20.551019,"percent":0.751227,"low":7.700371,"twenty":10.042807,"median":17.659092,"eighty":24.223543,"high":35.240461,"avg":17.784559,"sd":6.930103,"marketCap":129741871597.59},"quantilePoints":[{"date":"2020-05-01","current":33.287209,"twenty":10.936939,"median":22.288206,"eighty":27.915788,"marketCap":122748871163.92},{"date":"2020-05-08","current":33.429348,"twenty":10.947749,"median":22.313398,"eighty":28.361828,"marketCap":121627238914.58},{"date":"2020-05-15","current":32.595691,"twenty":10.949613,"median":22.330456,"eighty":28.489712,"marketCap":118247569927.49},{"date":"2020-05-22","current":32.461152,"twenty":10.950809,"median":22.368981,"eighty":28.664689,"marketCap":118529173787.58},{"date":"2020-05-29","current":32.711543,"twenty":10.957417,"median":22.45326,"eighty":28.739014,"marketCap":121900047291.83},{"date":"2020-06-05","current":33.320704,"twenty":10.961705,"median":22.504413,"eighty":28.869762,"marketCap":126404479866.46},{"date":"2020-06-12","current":33.26848,"twenty":10.97427,"median":22.552737,"eighty":29.165734,"marketCap":125312894610.63},{"date":"2020-06-19","current":35.174448,"twenty":10.980961,"median":22.560851,"eighty":29.253683,"marketCap":131987852645.25},{"date":"2020-06-26","current":34.045816,"twenty":10.987268,"median":22.616571,"eighty":29.711727,"marketCap":127924643785.45},{"date":"2020-07-02","current":34.367214,"twenty":10.994274,"median":22.648355,"eighty":29.771242,"marketCap":129509727296.23},{"date":"2020-07-10","current":33.233448,"twenty":10.9995,"median":22.663506,"eighty":32.384166,"marketCap":126030678803.03},{"date":"2020-07-17","current":34.840553,"twenty":11.002375,"median":22.680357,"eighty":32.642032,"marketCap":133469182626.29},{"date":"2020-07-24","current":33.192336,"twenty":11.004309,"median":22.714228,"eighty":32.855777,"marketCap":129403011819.03},{"date":"2020-07-31","current":10.079688,"twenty":10.9995,"median":22.705861,"eighty":32.972702,"marketCap":131609513547.85},{"date":"2020-08-07","current":9.946507,"twenty":10.971294,"median":22.66842,"eighty":32.855777,"marketCap":129396034746.58},{"date":"2020-08-14","current":9.727952,"twenty":10.948867,"median":22.658549,"eighty":32.749663,"marketCap":127031956635.12},{"date":"2020-08-21","current":9.828123,"twenty":10.929747,"median":22.644775,"eighty":32.720989,"marketCap":127780651499.59},{"date":"2020-08-28","current":9.679005,"twenty":10.883242,"median":22.578254,"eighty":32.71485,"marketCap":127069323852.74},{"date":"2020-09-04","current":9.512813,"twenty":10.85502,"median":22.559456,"eighty":32.642032,"marketCap":123841606541.64},{"date":"2020-09-11","current":9.96472,"twenty":10.823199,"median":22.547298,"eighty":32.561309,"marketCap":130185382800.66},{"date":"2020-09-18","current":10.067167,"twenty":10.684765,"median":22.493564,"eighty":32.490302,"marketCap":131820291420.1},{"date":"2020-09-25","current":9.858857,"twenty":10.595525,"median":22.444418,"eighty":32.458162,"marketCap":126422921729.99},{"date":"2020-10-02","current":9.798527,"twenty":10.526117,"median":22.342652,"eighty":32.407337,"marketCap":126679565248.92},{"date":"2020-10-09","current":9.824708,"twenty":10.410161,"median":22.324584,"eighty":32.285505,"marketCap":128128683268.34},{"date":"2020-10-16","current":9.793052,"twenty":10.315413,"median":22.302943,"eighty":31.257628,"marketCap":126623612278.58},{"date":"2020-10-23","current":9.441308,"twenty":10.238589,"median":22.261435,"eighty":29.811136,"marketCap":123347203619.79},{"date":"2020-10-30","current":8.661295,"twenty":10.199611,"median":22.234806,"eighty":29.773341,"marketCap":113280166110.01},{"date":"2020-11-06","current":9.327376,"twenty":10.132097,"median":22.205679,"eighty":29.767042,"marketCap":124442629581.55},{"date":"2020-11-13","current":9.605003,"twenty":10.089923,"median":22.112471,"eighty":29.762798,"marketCap":127479835927.15},{"date":"2020-11-20","current":9.6106,"twenty":10.079688,"median":22.081393,"eighty":29.73408,"marketCap":127917182157.26},{"date":"2020-11-27","current":9.538955,"twenty":10.057978,"median":22.005256,"eighty":29.655002,"marketCap":127995801275.71},{"date":"2020-12-04","current":9.358721,"twenty":10.040076,"median":21.945075,"eighty":29.437865,"marketCap":127467141893.2},{"date":"2020-12-11","current":8.790033,"twenty":10.022546,"median":21.91943,"eighty":29.296005,"marketCap":119489512407.95},{"date":"2020-12-18","current":8.844887,"twenty":9.993694,"median":21.901999,"eighty":29.279125,"marketCap":121396802063.1},{"date":"2020-12-24","current":8.769883,"twenty":9.976103,"median":21.881466,"eighty":29.245202,"marketCap":119941986349.01},{"date":"2020-12-31","current":8.810183,"twenty":9.961936,"median":21.873052,"eighty":29.24273,"marketCap":120950078152.91},{"date":"2021-01-08","current":8.820259,"twenty":9.95106,"median":21.862976,"eighty":29.210969,"marketCap":121221849881.21},{"date":"2021-01-15","current":9.126992,"twenty":9.936588,"median":21.828735,"eighty":29.197581,"marketCap":123845036018.62},{"date":"2021-01-22","current":9.119156,"twenty":9.919292,"median":21.813001,"eighty":29.173346,"marketCap":124582207014},{"date":"2021-01-29","current":8.636715,"twenty":9.906894,"median":21.809329,"eighty":29.059102,"marketCap":117661873131.83},{"date":"2021-02-05","current":8.176599,"twenty":9.88162,"median":21.779975,"eighty":28.982923,"marketCap":120922774999.4},{"date":"2021-02-12","current":7.987538,"twenty":9.856239,"median":21.763827,"eighty":28.950951,"marketCap":119014418424.43},{"date":"2021-02-19","current":7.870014,"twenty":9.848372,"median":21.763595,"eighty":28.901957,"marketCap":117391358460.33},{"date":"2021-02-26","current":7.746359,"twenty":9.840411,"median":21.746147,"eighty":28.832667,"marketCap":115225330598.91},{"date":"2021-03-05","current":7.860937,"twenty":9.827943,"median":21.729717,"eighty":28.787173,"marketCap":115132662522.04},{"date":"2021-03-12","current":8.118972,"twenty":9.808685,"median":21.685029,"eighty":28.757776,"marketCap":119210132761.26},{"date":"2021-03-19","current":8.502978,"twenty":9.798186,"median":21.612115,"eighty":28.742096,"marketCap":124417528040.94},{"date":"2021-03-26","current":8.489771,"twenty":9.792219,"median":21.598158,"eighty":28.727957,"marketCap":123096173961.55},{"date":"2021-04-01","current":8.553964,"twenty":9.788159,"median":21.54258,"eighty":28.711437,"marketCap":123735063715.73},{"date":"2021-04-09","current":8.641332,"twenty":9.782356,"median":21.526019,"eighty":28.694903,"marketCap":126246626546.64},{"date":"2021-04-16","current":8.636253,"twenty":9.769654,"median":21.512492,"eighty":28.66049,"marketCap":127185060180.88},{"date":"2021-04-23","current":8.669778,"twenty":9.761091,"median":21.479045,"eighty":28.625112,"marketCap":128556561372.57},{"date":"2021-04-30","current":8.936356,"twenty":9.755206,"median":21.457669,"eighty":28.539275,"marketCap":131116008424.15},{"date":"2021-05-07","current":8.761308,"twenty":9.751942,"median":21.433287,"eighty":28.492512,"marketCap":129875631253.04},{"date":"2021-05-14","current":8.892563,"twenty":9.741584,"median":21.426198,"eighty":28.475014,"marketCap":131645337996.12},{"date":"2021-05-21","current":9.047404,"twenty":9.729833,"median":21.41999,"eighty":28.415141,"marketCap":134492606805.61},{"date":"2021-05-28","current":9.019717,"twenty":9.710422,"median":21.40835,"eighty":28.40452,"marketCap":134081034734.92},{"date":"2021-06-04","current":8.826935,"twenty":9.707463,"median":21.392314,"eighty":28.379325,"marketCap":130991765454.43},{"date":"2021-06-11","current":9.116284,"twenty":9.694395,"median":21.363939,"eighty":28.361828,"marketCap":134500207706.54},{"date":"2021-06-18","current":9.021943,"twenty":9.679005,"median":21.290156,"eighty":28.230746,"marketCap":130457184786.01},{"date":"2021-06-25","current":9.04963,"twenty":9.672117,"median":21.229467,"eighty":28.073267,"marketCap":131826509965.36},{"date":"2021-07-02","current":9.013739,"twenty":9.660792,"median":21.196129,"eighty":27.996278,"marketCap":130199639608.01},{"date":"2021-07-09","current":8.944008,"twenty":9.658829,"median":21.16444,"eighty":27.931886,"marketCap":129422313900.82},{"date":"2021-07-16","current":9.010663,"twenty":9.638085,"median":21.140332,"eighty":27.848598,"marketCap":129770992211.6},{"date":"2021-07-23","current":9.031172,"twenty":9.62122,"median":21.117164,"eighty":27.80391,"marketCap":129576758627.22},{"date":"2021-07-30","current":18.87536,"twenty":9.610467,"median":21.085355,"eighty":27.796937,"marketCap":129351074870.7},{"date":"2021-08-06","current":18.73975,"twenty":9.613461,"median":21.013453,"eighty":27.749237,"marketCap":127349176618.04},{"date":"2021-08-13","current":19.000477,"twenty":9.62122,"median":20.964049,"eighty":27.709316,"marketCap":129532398703.09},{"date":"2021-08-20","current":19.713131,"twenty":9.626758,"median":20.922915,"eighty":27.702194,"marketCap":133040601577.1},{"date":"2021-08-27","current":19.159086,"twenty":9.631579,"median":20.849323,"eighty":27.682689,"marketCap":130505881690.84},{"date":"2021-09-03","current":19.087386,"twenty":9.636484,"median":20.812207,"eighty":27.640133,"marketCap":131037228600.12},{"date":"2021-09-10","current":17.788527,"twenty":9.637931,"median":20.810313,"eighty":27.621196,"marketCap":121557039339.96},{"date":"2021-09-17","current":17.718998,"twenty":9.644258,"median":20.781658,"eighty":27.597623,"marketCap":120158061709.12},{"date":"2021-09-24","current":17.821119,"twenty":9.653374,"median":20.756596,"eighty":27.571856,"marketCap":120553399377.05},{"date":"2021-10-01","current":17.949313,"twenty":9.657986,"median":20.686673,"eighty":27.533829,"marketCap":120210038226.29},{"date":"2021-10-08","current":18.316512,"twenty":9.65882,"median":20.60166,"eighty":27.49647,"marketCap":122456300914.25},{"date":"2021-10-15","current":18.21668,"twenty":9.659965,"median":20.367209,"eighty":27.481537,"marketCap":122085570969.84},{"date":"2021-10-22","current":18.492625,"twenty":9.660762,"median":19.534967,"eighty":27.418547,"marketCap":124266480579.27},{"date":"2021-10-29","current":17.57188,"twenty":9.660792,"median":19.400258,"eighty":27.363912,"marketCap":125449567069.84},{"date":"2021-11-05","current":17.984594,"twenty":9.662246,"median":19.19059,"eighty":27.343794,"marketCap":128307008370.7},{"date":"2021-11-12","current":18.139856,"twenty":9.664147,"median":19.148222,"eighty":27.315537,"marketCap":128214619445.91},{"date":"2021-11-19","current":18.074795,"twenty":9.669177,"median":19.129754,"eighty":27.3008,"marketCap":126337351612.14},{"date":"2021-11-26","current":17.283895,"twenty":9.672117,"median":19.062399,"eighty":27.290992,"marketCap":120754520924.52},{"date":"2021-12-03","current":17.031784,"twenty":9.672185,"median":18.974404,"eighty":27.274231,"marketCap":118697631154.76},{"date":"2021-12-10","current":17.593219,"twenty":9.673996,"median":18.883829,"eighty":27.261649,"marketCap":122887806332.16},{"date":"2021-12-17","current":17.666414,"twenty":9.676585,"median":18.822313,"eighty":27.226753,"marketCap":122981663791.86},{"date":"2021-12-23","current":17.924629,"twenty":9.677102,"median":18.797147,"eighty":27.187184,"marketCap":125231028798.23},{"date":"2021-12-31","current":18.010023,"twenty":9.680432,"median":18.68789,"eighty":27.152672,"marketCap":126457276638.23},{"date":"2022-01-07","current":18.01409,"twenty":9.687791,"median":18.583882,"eighty":27.099359,"marketCap":126127227506.24},{"date":"2022-01-14","current":18.425049,"twenty":9.694395,"median":18.458837,"eighty":27.042911,"marketCap":129932901404.91},{"date":"2022-01-21","current":18.490113,"twenty":9.694395,"median":18.493429,"eighty":27.028616,"marketCap":129474826588.41},{"date":"2022-01-28","current":19.165142,"twenty":9.694395,"median":18.494232,"eighty":27.028595,"marketCap":132074546389.11},{"date":"2022-02-04","current":18.213402,"twenty":9.69608,"median":18.572578,"eighty":27.025402,"marketCap":129696764676.74},{"date":"2022-02-11","current":18.927495,"twenty":9.697119,"median":18.616113,"eighty":27.010232,"marketCap":134335997389.37},{"date":"2022-02-18","current":18.766118,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":132345369395.97},{"date":"2022-02-25","current":18.833821,"twenty":9.697119,"median":18.575534,"eighty":27.010232,"marketCap":132044689275.57},{"date":"2022-03-04","current":17.617959,"twenty":9.697119,"median":18.491369,"eighty":27.010232,"marketCap":119664437682.82},{"date":"2022-03-11","current":18.783661,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127973204254.43},{"date":"2022-03-18","current":18.717451,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":128848117335.18},{"date":"2022-03-25","current":18.683343,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127751282161.3},{"date":"2022-04-01","current":18.889374,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":129744565958.06},{"date":"2022-04-08","current":20.960102,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":141869390625.41},{"date":"2022-04-14","current":20.695242,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":139183497682.91},{"date":"2022-04-22","current":20.346108,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":136481434838.85},{"date":"2022-04-29","current":18.952765,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":133142723720.1},{"date":"2022-05-06","current":18.179144,"twenty":9.697119,"median":18.493429,"eighty":27.010232,"marketCap":128384549744.68},{"date":"2022-05-13","current":18.692394,"twenty":9.697119,"median":18.527753,"eighty":27.010232,"marketCap":129700736023.73},{"date":"2022-05-20","current":19.16256,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":134758546837.22},{"date":"2022-05-27","current":19.177546,"twenty":9.697119,"median":18.665261,"eighty":27.010232,"marketCap":136958987699.81},{"date":"2022-06-03","current":18.744225,"twenty":9.697119,"median":18.681313,"eighty":27.010232,"marketCap":133921762001.07},{"date":"2022-06-10","current":18.146643,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":127291929717.98},{"date":"2022-06-17","current":17.640852,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":123044805550.91},{"date":"2022-06-24","current":18.83789,"twenty":9.696859,"median":18.692394,"eighty":27.014025,"marketCap":132461365342.83},{"date":"2022-07-01","current":18.293193,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126838383992.09},{"date":"2022-07-08","current":18.63272,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126418025181.68},{"date":"2022-07-15","current":18.795918,"twenty":9.696859,"median":18.717451,"eighty":27.014025,"marketCap":126431471445.01},{"date":"2022-07-22","current":18.263208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124455681540.58},{"date":"2022-07-29","current":18.321107,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124140260314.16},{"date":"2022-08-05","current":18.377647,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123992191551.9},{"date":"2022-08-12","current":16.132936,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109885258896.75},{"date":"2022-08-19","current":15.415581,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102816971778.11},{"date":"2022-08-26","current":15.459,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102642813930.03},{"date":"2022-09-02","current":15.37405,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102457677511.04},{"date":"2022-09-09","current":15.328743,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102237792167.67},{"date":"2022-09-16","current":15.453336,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102882856127.48},{"date":"2022-09-23","current":14.877565,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96093011237.72},{"date":"2022-09-30","current":14.800166,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96408611153.17},{"date":"2022-10-07","current":15.132414,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":98274151179.98},{"date":"2022-10-14","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":99690906745.93},{"date":"2022-10-21","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":100326441165.16},{"date":"2022-10-28","current":16.846401,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":107356651323.46},{"date":"2022-11-04","current":17.17473,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109112652999.6},{"date":"2022-11-11","current":16.109615,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":106637600025.82},{"date":"2022-11-18","current":16.83559,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":111812739546.11},{"date":"2022-11-25","current":17.129097,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":114152420880.73},{"date":"2022-12-02","current":16.782758,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":112782528627.45},{"date":"2022-12-09","current":17.361946,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":117264953276.43},{"date":"2022-12-16","current":17.144751,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":116510134592.3},{"date":"2022-12-23","current":17.802208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121183588329.26},{"date":"2022-12-30","current":17.579142,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":120406882967.83},{"date":"2023-01-06","current":17.829602,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121279894677.35},{"date":"2023-01-13","current":17.841342,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123710007946.55},{"date":"2023-01-20","current":17.659092,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":122645342505.42},{"date":"2023-01-27","current":17.429425,"twenty":9.703429,"median":18.719457,"eighty":27.014025,"marketCap":121260511615.28},{"date":"2023-02-03","current":12.687149,"twenty":9.709538,"median":18.719457,"eighty":27.014025,"marketCap":115251355422.68},{"date":"2023-02-10","current":13.217643,"twenty":9.726396,"median":18.719457,"eighty":27.014025,"marketCap":118159855219.99},{"date":"2023-02-17","current":13.277249,"twenty":9.741642,"median":18.719457,"eighty":27.014025,"marketCap":118515515804.01},{"date":"2023-02-24","current":13.411211,"twenty":9.752083,"median":18.719457,"eighty":27.014025,"marketCap":118448244308.93},{"date":"2023-03-03","current":13.302322,"twenty":9.756767,"median":18.719457,"eighty":27.014025,"marketCap":118034490740.94},{"date":"2023-03-10","current":13.357512,"twenty":9.764714,"median":18.719457,"eighty":27.014025,"marketCap":119257397037.12},{"date":"2023-03-17","current":13.394803,"twenty":9.773462,"median":18.719457,"eighty":27.014025,"marketCap":119526591543.55},{"date":"2023-03-24","current":14.48369,"twenty":9.785178,"median":18.719457,"eighty":27.014025,"marketCap":130424881067.13},{"date":"2023-03-31","current":14.952061,"twenty":9.790694,"median":18.718645,"eighty":27.010232,"marketCap":135988374469.8},{"date":"2023-04-06","current":15.280218,"twenty":9.798413,"median":18.718645,"eighty":27.010232,"marketCap":139686260171.45},{"date":"2023-04-14","current":15.221476,"twenty":9.80991,"median":18.730688,"eighty":27.025402,"marketCap":140825574178.82},{"date":"2023-04-19","current":15.209543,"twenty":9.82744,"median":18.731112,"eighty":27.026041,"marketCap":139558349488.11},{"date":"2023-04-27","current":15.21474,"twenty":9.850092,"median":18.73173,"eighty":27.027318,"marketCap":140140612943.9},{"date":"2023-05-05","current":15.175888,"twenty":9.902113,"median":18.731826,"eighty":27.028595,"marketCap":139552044885.56},{"date":"2023-05-12","current":14.838181,"twenty":9.939677,"median":18.731826,"eighty":27.028595,"marketCap":135403671391.13},{"date":"2023-05-19","current":15.184854,"twenty":9.959028,"median":18.731826,"eighty":27.028595,"marketCap":136642429723.27},{"date":"2023-05-26","current":14.853124,"twenty":9.978835,"median":18.733652,"eighty":27.028599,"marketCap":133126940240.24},{"date":"2023-06-02","current":14.192653,"twenty":10.040758,"median":18.733652,"eighty":27.028599,"marketCap":127343787455.44},{"date":"2023-06-09","current":14.256612,"twenty":10.09699,"median":18.733652,"eighty":27.028599,"marketCap":128372490395.43},{"date":"2023-06-16","current":14.295467,"twenty":10.208772,"median":18.72486,"eighty":27.028599,"marketCap":130508209942.1},{"date":"2023-06-23","current":14.734821,"twenty":10.181908,"median":18.697387,"eighty":27.028603,"marketCap":134961533039.24},{"date":"2023-06-30","current":14.675045,"twenty":10.181908,"median":18.683343,"eighty":27.028603,"marketCap":133521342889.49},{"date":"2023-07-07","current":14.039924,"twenty":10.181908,"median":18.651241,"eighty":27.028603,"marketCap":127451273212.04},{"date":"2023-07-14","current":14.002564,"twenty":10.181908,"median":18.628706,"eighty":27.028603,"marketCap":130982117535.26},{"date":"2023-07-21","current":14.736316,"twenty":10.181908,"median":18.609955,"eighty":27.028603,"marketCap":137261916493.54},{"date":"2023-07-28","current":14.230057,"twenty":10.155044,"median":18.575133,"eighty":27.028608,"marketCap":130696325708.32},{"date":"2023-08-04","current":13.64955,"twenty":10.155044,"median":18.53333,"eighty":27.028608,"marketCap":128783719369.32},{"date":"2023-08-11","current":14.107345,"twenty":10.155044,"median":18.465688,"eighty":27.028608,"marketCap":133909438393.92},{"date":"2023-08-18","current":14.257236,"twenty":10.155044,"median":18.417461,"eighty":27.028608,"marketCap":133639295738.06},{"date":"2023-08-25","current":14.360528,"twenty":10.155044,"median":18.371061,"eighty":27.028608,"marketCap":134024340566.45},{"date":"2023-09-01","current":14.34598,"twenty":10.155044,"median":18.34457,"eighty":27.028608,"marketCap":134077344689.8},{"date":"2023-09-08","current":14.597664,"twenty":10.155044,"median":18.325923,"eighty":27.028608,"marketCap":134604678073.84},{"date":"2023-09-15","current":14.95555,"twenty":10.155044,"median":18.296091,"eighty":27.016307,"marketCap":137463437822.93},{"date":"2023-09-22","current":14.853801,"twenty":10.12818,"median":18.276078,"eighty":27.020855,"marketCap":136484543397.31},{"date":"2023-09-29","current":14.763602,"twenty":10.12818,"median":18.246983,"eighty":26.983029,"marketCap":134423031209.85},{"date":"2023-10-06","current":14.868349,"twenty":10.12818,"median":18.218159,"eighty":26.938973,"marketCap":134892153493.37},{"date":"2023-10-13","current":15.040019,"twenty":10.12818,"median":18.16832,"eighty":26.598464,"marketCap":136737545848.28},{"date":"2023-10-20","current":14.380784,"twenty":10.12818,"median":18.144978,"eighty":26.402781,"marketCap":131062102932.84},{"date":"2023-10-27","current":11.85036,"twenty":10.092665,"median":18.111628,"eighty":26.025777,"marketCap":107534279335.51},{"date":"2023-11-03","current":11.80423,"twenty":10.092665,"median":18.07332,"eighty":25.817137,"marketCap":113606320100.85},{"date":"2023-11-10","current":11.775378,"twenty":10.092665,"median":18.059836,"eighty":25.817137,"marketCap":114360557197.64},{"date":"2023-11-17","current":11.879108,"twenty":10.092665,"median":18.023837,"eighty":25.817137,"marketCap":116984566837.93},{"date":"2023-11-24","current":11.946878,"twenty":10.092665,"median":18.009006,"eighty":25.817137,"marketCap":118113843833.15},{"date":"2023-12-01","current":11.863894,"twenty":10.092665,"median":17.972228,"eighty":25.817137,"marketCap":117306211282.58},{"date":"2023-12-08","current":11.912301,"twenty":10.09699,"median":17.952065,"eighty":25.812238,"marketCap":116514105188.26},{"date":"2023-12-15","current":12.129442,"twenty":10.09699,"median":17.934507,"eighty":25.812238,"marketCap":120907663627.27},{"date":"2023-12-22","current":12.356264,"twenty":10.09699,"median":17.886813,"eighty":25.812238,"marketCap":123141571763.22},{"date":"2023-12-29","current":12.414352,"twenty":10.092665,"median":17.852857,"eighty":25.817137,"marketCap":124666059594.59},{"date":"2024-01-05","current":12.928851,"twenty":10.088339,"median":17.827036,"eighty":25.822036,"marketCap":128452561703.01},{"date":"2024-01-12","current":13.228975,"twenty":10.088339,"median":17.806558,"eighty":25.822036,"marketCap":131304891825.05},{"date":"2024-01-19","current":13.006481,"twenty":10.084014,"median":17.776767,"eighty":25.826935,"marketCap":128114681751.41},{"date":"2024-01-26","current":12.735372,"twenty":10.088339,"median":17.745072,"eighty":25.822036,"marketCap":125131555256.31},{"date":"2024-02-02","current":20.334039,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":119118906599.05},{"date":"2024-02-09","current":20.085581,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116751493787.94},{"date":"2024-02-16","current":20.076293,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116634730314.15},{"date":"2024-02-23","current":20.830953,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":121673497945.92},{"date":"2024-03-01","current":20.187328,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":117837605321.59},{"date":"2024-03-08","current":20.275189,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119656853104.92},{"date":"2024-03-15","current":20.393108,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119946394721.71},{"date":"2024-03-22","current":20.497155,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":120191807946.57},{"date":"2024-03-28","current":21.03126,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122670991700.15},{"date":"2024-04-05","current":20.194264,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":118454296559.85},{"date":"2024-04-12","current":19.993107,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115628981743.6},{"date":"2024-04-19","current":20.090217,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115682634323.95},{"date":"2024-04-26","current":25.102236,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122028864510.98},{"date":"2024-05-03","current":25.121496,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":121965711156.52},{"date":"2024-05-10","current":25.955211,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":126909542740.01},{"date":"2024-05-17","current":24.564329,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121166222484.78},{"date":"2024-05-24","current":24.660746,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121128331641.95},{"date":"2024-05-31","current":24.726861,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121676961247.02},{"date":"2024-06-07","current":25.104265,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":123964258787.81},{"date":"2024-06-14","current":23.809521,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":116305279179.76},{"date":"2024-06-21","current":24.137339,"twenty":10.088339,"median":17.71521,"eighty":25.90586,"marketCap":117375957434.63},{"date":"2024-06-28","current":24.776447,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":120367749389.79},{"date":"2024-07-05","current":25.051924,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":122903385527.57},{"date":"2024-07-12","current":26.005076,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":128286809560.82},{"date":"2024-07-15","current":25.462386,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":126116902211.31},{"date":"2024-08-02","current":28.58221,"twenty":10.045539,"median":17.667431,"eighty":25.970775,"marketCap":129963975586.71},{"date":"2024-08-09","current":28.611937,"twenty":10.045539,"median":17.667431,"eighty":26.395222,"marketCap":131603672136.16},{"date":"2024-08-16","current":29.365903,"twenty":10.045539,"median":17.667431,"eighty":26.965608,"marketCap":135991482271.53},{"date":"2024-08-23","current":29.827758,"twenty":10.045539,"median":17.667431,"eighty":27.30154,"marketCap":139679917173.16},{"date":"2024-08-30","current":30.083408,"twenty":10.045539,"median":17.667431,"eighty":27.737312,"marketCap":140486982478.95},{"date":"2024-09-06","current":31.076279,"twenty":10.045539,"median":17.667431,"eighty":27.755808,"marketCap":145252320920.18},{"date":"2024-09-13","current":30.737395,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":143002491189.58},{"date":"2024-09-20","current":30.78296,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144554419337.27},{"date":"2024-09-27","current":30.616469,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144270741555.83},{"date":"2024-10-04","current":30.241865,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":140433638887.54},{"date":"2024-10-11","current":29.775602,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":137150593697.15},{"date":"2024-10-18","current":29.977793,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":136855848164.59},{"date":"2024-10-25","current":29.757762,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":135513851100.67},{"date":"2024-10-31","current":27.016329,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":132177608883.82},{"date":"2024-11-08","current":26.635368,"twenty":10.044628,"median":17.666414,"eighty":26.885017,"marketCap":129456333845.32},{"date":"2024-11-15","current":25.402919,"twenty":10.044628,"median":17.666414,"eighty":26.404422,"marketCap":121101937530.68},{"date":"2024-11-22","current":25.92038,"twenty":10.044628,"median":17.666414,"eighty":25.927346,"marketCap":122518864801.22},{"date":"2024-11-29","current":25.619919,"twenty":10.044628,"median":17.666414,"eighty":25.699083,"marketCap":121788536423.67},{"date":"2024-12-06","current":25.644957,"twenty":10.044628,"median":17.666414,"eighty":25.611269,"marketCap":122139495847.16},{"date":"2024-12-13","current":24.807559,"twenty":10.044628,"median":17.666414,"eighty":25.528111,"marketCap":117246552266.62},{"date":"2024-12-20","current":25.394572,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":118799775303.16},{"date":"2024-12-27","current":25.950983,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":121782054794.83},{"date":"2025-01-03","current":25.836919,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":119394068299.66},{"date":"2025-01-10","current":26.476134,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":122813940759.73},{"date":"2025-01-17","current":27.190583,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":126128028900.56},{"date":"2025-01-24","current":27.736112,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":130118603784.49},{"date":"2025-01-31","current":22.679241,"twenty":10.043718,"median":17.662753,"eighty":25.458421,"marketCap":135796476672.57},{"date":"2025-02-07","current":22.453317,"twenty":10.043718,"median":17.662753,"eighty":25.395685,"marketCap":133815994648.27},{"date":"2025-02-14","current":22.527177,"twenty":10.043718,"median":17.662753,"eighty":25.302609,"marketCap":135139535422.45},{"date":"2025-02-21","current":23.475533,"twenty":10.043718,"median":17.662753,"eighty":25.274251,"marketCap":136588490535.79},{"date":"2025-02-28","current":23.529645,"twenty":10.043718,"median":17.662753,"eighty":25.156716,"marketCap":136134051560.87},{"date":"2025-03-07","current":24.715596,"twenty":10.042807,"median":17.659092,"eighty":25.048936,"marketCap":148818188841.24},{"date":"2025-03-14","current":23.949012,"twenty":10.042807,"median":17.659092,"eighty":24.864048,"marketCap":144656712656.17},{"date":"2025-03-21","current":23.863334,"twenty":10.042807,"median":17.659092,"eighty":24.801725,"marketCap":143967164905.6},{"date":"2025-03-28","current":22.763528,"twenty":10.042807,"median":17.659092,"eighty":24.715596,"marketCap":136620485714.59},{"date":"2025-04-04","current":21.134417,"twenty":10.042807,"median":17.659092,"eighty":24.626125,"marketCap":130072347841.49},{"date":"2025-04-11","current":19.729859,"twenty":10.043718,"median":17.662753,"eighty":24.453364,"marketCap":122690991838.72},{"date":"2025-04-17","current":19.969823,"twenty":10.043718,"median":17.662753,"eighty":24.305248,"marketCap":126259056108.71},{"date":"2025-04-24","current":20.551019,"twenty":10.042807,"median":17.659092,"eighty":24.223543,"marketCap":129741871597.59}],"updateTime":1745639062899}}}